Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/1999
06/24/1999CA2314355A1 Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors
06/23/1999EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor
06/23/1999EP0923935A1 External preparation for curing lesioned tissues
06/23/1999EP0923585A1 Phosphinate based inhibitors of matrix metalloproteases
06/23/1999EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives
06/23/1999EP0923569A1 Butyric acid matrix metalloproteinase inhibitors
06/23/1999EP0923567A1 Benzylamine derivatives, their preparation and their application in therapeutics
06/23/1999EP0923563A1 1,4-heterocyclic metallprotease inhibitors
06/23/1999EP0923561A1 Heterocyclic metalloprotease inhibitors
06/23/1999EP0923550A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
06/23/1999EP0923547A1 Bidentate metalloprotease inhibitors
06/23/1999EP0923536A1 Arylcycloalkane carboxylic esters, their use, pharmaceutical compositions and preparation
06/23/1999EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
06/23/1999EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
06/23/1999EP0923373A1 Il-8 receptor antagonists
06/23/1999CN1220262A 7-phenyl-1,4-stable derivative, its preparing method and medicine containing said compound
06/23/1999CN1220158A Weitongxiao traditional Chinese medicine for curing gastro-duodenal ulcer and gastrorrhagia
06/23/1999CN1043762C Compound used for excitary amino acid receptor antagonists and its drug composition
06/22/1999US5914402 Process for preparing 1-aryl-4-oxopyrrolo 3,2-c! quinoline derivatives
06/22/1999US5914395 Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells
06/22/1999US5914338 Heterocyclic compounds and their preparation and use
06/22/1999US5914260 Fish pancreatic disease virus
06/22/1999US5914135 Consists of a preservative-free calcium carbonate liquid antacid conataining magnesium hydroxide as ph adjusting agent; microbiodcides; treats gastrointestinal disorder such as acid indigestin, heartburn, dyspepsia, sour stomach
06/22/1999US5914118 Multi-layered drug containing film preparation having powder adhesive thereon
06/22/1999CA2151674C Methods of administering crf antagonists
06/19/1999WO1999032139A1 Improved interferon polymer conjugates
06/17/1999WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999WO1999029870A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999WO1999029856A1 Restin and methods of use thereof
06/17/1999WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof
06/17/1999WO1999029726A1 Phospholipase inhibitor
06/17/1999WO1999029697A1 Pharmaceuticals
06/17/1999WO1999029687A1 (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
06/17/1999WO1999029669A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
06/17/1999WO1999029662A2 Urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
06/17/1999WO1999029350A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999WO1999029320A1 Novel administration form comprising an acid-labile active compound
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999029299A1 Novel suppository form comprising an acid-labile active compound
06/17/1999WO1999017787A3 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/17/1999WO1999017742A3 Taste masked formulations
06/17/1999WO1999015210A3 Bioadhesive compositions and methods for topical administration of active agents
06/17/1999WO1999013064A3 Viral infection of cells using viral vectors
06/17/1999WO1999010292A3 Robustaflavone, intermediates and analogues and method for preparation thereof
06/17/1999DE19754796A1 Neue, von Azacycloalkanen abgeleitete Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New-derived azacycloalkanes urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999DE19754795A1 Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung New urethanes, their thio and Dithioanaloga, salts thereof, pharmaceutical compositions containing them and their use, and processes for their preparation
06/17/1999CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999CA2313705A1 Restin and methods of use thereof
06/17/1999CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
06/17/1999CA2312844A1 Pharmaceuticals
06/17/1999CA2312698A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999CA2309388A1 New urethanes derived from azacycloalkanes, the thio and dithio analogues thereof, the salts thereof, pharmaceutical compositions containing these compounds and their use as well as processes for preparing them
06/16/1999EP0922459A1 Pharmaceutical compositions comprising D-galactose and the use thereof
06/16/1999EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof
06/16/1999EP0922030A1 Arylsulfonylamino hydroxamic acid derivatives
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0921809A1 Use of prolactin as a tgf-beta antagonist
06/16/1999EP0921787A1 ADMINISTRATION REGIMEN OF H+,K+-ATPase INHIBITORS
06/16/1999EP0711283B1 Tetrahydro-1h-benzazepinones and hexahydroazepinones as selective cholecystokinin-b receptor antagonists
06/16/1999EP0583421B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
06/16/1999CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
06/16/1999CN1219874A Preparation for percutaneous administration
06/16/1999CN1219872A Compositions and method for treating or preventing diseases of body passageways
06/16/1999CN1219533A Sulfonamide-substituted fused 5-membered ring compounds, their use as medicament, and pharmaceutical preparation comprising them
06/16/1999CN1219422A Medicine for curing hepatic and gallbladder diseases
06/16/1999CN1219398A Gastric medicine and its preparation method
06/16/1999CN1043643C Cyclohexan derivative and its use for preparing medicine
06/16/1999CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them
06/15/1999US5912360 Dioxolane intermediates
06/15/1999US5912270 Anti-inflammatory compounds
06/15/1999US5912260 Gastrin and CCK antagonists
06/15/1999US5912244 Muscle disorders, breathing disorders and urinary incontinence
06/15/1999US5912235 Ring-contracted n-demethyl-n-isopropyl-erythromycin-a-spiroacetal compounds, gastrointestinally effective motilin-agonistic properties
06/15/1999CA2099855C Antigastritis agent
06/10/1999WO1999028493A2 Method for identifying inhibitors of g-protein coupled receptor hibef51
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028342A2 Low-voltage activated calcium channel compositions and methods
06/10/1999WO1999028322A1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
06/10/1999WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999WO1999027953A1 Chemoprotective bacterial strains
06/10/1999WO1999027941A1 Oral antioxidant preparation comprising selenium and reduced glutathione
06/10/1999WO1999027927A1 Synergistic antimicrobial compositions
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1999007737A3 Lsr receptor, cloning and uses
06/10/1999DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders
06/10/1999CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999CA2312811A1 Synergistic antimicrobial compositions
06/10/1999CA2312464A1 Oral antioxidant preparation comprising selenium and reduced glutathione
06/10/1999CA2312195A1 Low-voltage activated calcium channel compositions and methods
06/10/1999CA2311798A1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
06/10/1999CA2311613A1 Chemoprotective bacterial strains
06/10/1999CA2310541A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/09/1999EP0920519A1 Phytase from bacillus subtilis, gene encoding said phytase, method for its production and use
06/09/1999EP0920507A2 Secreted proteins and polynucleotides encoding them
06/09/1999EP0920425A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
06/09/1999EP0920424A1 Non-peptide bombesin receptor antagonists
06/09/1999EP0920331A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
06/09/1999EP0920330A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
06/09/1999EP0920320A2 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
1 ... 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 ... 1258